questionsmedicales.fr
Procédures de chirurgie opératoire
Procédures de chirurgie oto-rhino-laryngologique
Évidement ganglionnaire cervical
Évidement ganglionnaire cervical : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
Échographie
Tomodensitométrie
Lymphadénopathie
Symptômes
Symptômes
5
Symptômes
Lymphadénopathie
Infection
Lymphadénopathie
Traitements
5
Radiothérapie
Chimiothérapie
Soins post-opératoires
Chirurgie
Facteurs de risque
5
Facteurs de risque
Cancer
Facteurs de risque
Cancer
Facteurs de risque
Cancer
Antécédents familiaux
Cancer
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Évidement ganglionnaire cervical : Questions médicales les plus fréquentes",
"headline": "Évidement ganglionnaire cervical : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Évidement ganglionnaire cervical : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-03-27",
"dateModified": "2025-03-22",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Évidement ganglionnaire cervical"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Procédures de chirurgie oto-rhino-laryngologique",
"url": "https://questionsmedicales.fr/mesh/D013517",
"about": {
"@type": "MedicalCondition",
"name": "Procédures de chirurgie oto-rhino-laryngologique",
"code": {
"@type": "MedicalCode",
"code": "D013517",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E04.580"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Évidement ganglionnaire cervical",
"alternateName": "Neck Dissection",
"code": {
"@type": "MedicalCode",
"code": "D037981",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Umamaheswar Duvvuri",
"url": "https://questionsmedicales.fr/author/Umamaheswar%20Duvvuri",
"affiliation": {
"@type": "Organization",
"name": "Department of Otolaryngology, University of Pittsburgh, 203 Lothrop Street, Suite 500, Pittsburgh, PA 15213, USA; Department of Veterans Affairs, Pittsburgh Health System, University Drive C, Pittsburgh, PA 15240, USA. Electronic address: duvvuriu@upmc.edu."
}
},
{
"@type": "Person",
"name": "Joe Iwanaga",
"url": "https://questionsmedicales.fr/author/Joe%20Iwanaga",
"affiliation": {
"@type": "Organization",
"name": "Clinical Anatomy Research Association in Oral and Maxillofacial Surgery, Fukuoka, Japan."
}
},
{
"@type": "Person",
"name": "R Shane Tubbs",
"url": "https://questionsmedicales.fr/author/R%20Shane%20Tubbs",
"affiliation": {
"@type": "Organization",
"name": "Clinical Anatomy Research Association in Oral and Maxillofacial Surgery, Fukuoka, Japan."
}
},
{
"@type": "Person",
"name": "Aman M Patel",
"url": "https://questionsmedicales.fr/author/Aman%20M%20Patel",
"affiliation": {
"@type": "Organization",
"name": "Department of Otolaryngology-Head and Neck Surgery, Rutgers New Jersey Medical School, Newark, New Jersey, USA."
}
},
{
"@type": "Person",
"name": "Afash Haleem",
"url": "https://questionsmedicales.fr/author/Afash%20Haleem",
"affiliation": {
"@type": "Organization",
"name": "Department of Otolaryngology-Head and Neck Surgery, Rutgers New Jersey Medical School, Newark, New Jersey, USA."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Identifying geographic atrophy.",
"datePublished": "2023-03-17",
"url": "https://questionsmedicales.fr/article/36943458",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1097/ICU.0000000000000952"
}
},
{
"@type": "ScholarlyArticle",
"name": "Future perspectives for treating patients with geographic atrophy.",
"datePublished": "2022-12-15",
"url": "https://questionsmedicales.fr/article/36520185",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s00417-022-05931-z"
}
},
{
"@type": "ScholarlyArticle",
"name": "[Monitoring of the progression of geographic atrophy with optical coherence tomography].",
"datePublished": "2023-07-07",
"url": "https://questionsmedicales.fr/article/37419965",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s00347-023-01891-9"
}
},
{
"@type": "ScholarlyArticle",
"name": "Clinical Characteristics and Progression of Geographic Atrophy in a Japanese Population.",
"datePublished": "2023-06-09",
"url": "https://questionsmedicales.fr/article/37302656",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.oret.2023.06.004"
}
},
{
"@type": "ScholarlyArticle",
"name": "Quantitative multimodal imaging of extensive macular atrophy with pseudodrusen and geographic atrophy with diffuse trickling pattern.",
"datePublished": "2023-02-01",
"url": "https://questionsmedicales.fr/article/36725879",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41598-023-28906-4"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Procédures de chirurgie opératoire",
"item": "https://questionsmedicales.fr/mesh/D013514"
},
{
"@type": "ListItem",
"position": 3,
"name": "Procédures de chirurgie oto-rhino-laryngologique",
"item": "https://questionsmedicales.fr/mesh/D013517"
},
{
"@type": "ListItem",
"position": 4,
"name": "Évidement ganglionnaire cervical",
"item": "https://questionsmedicales.fr/mesh/D037981"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Évidement ganglionnaire cervical - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Évidement ganglionnaire cervical",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-07",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Évidement ganglionnaire cervical",
"description": "Comment diagnostiquer un cancer nécessitant un évidement ganglionnaire ?\nQuels tests sont utilisés pour évaluer les ganglions lymphatiques ?\nQuels signes cliniques indiquent un besoin d'évidement ?\nQuelle est l'importance de l'examen histologique ?\nQuand un scanner est-il recommandé ?",
"url": "https://questionsmedicales.fr/mesh/D037981?mesh_terms=Geographic+Atrophy#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Évidement ganglionnaire cervical",
"description": "Quels symptômes peuvent indiquer un cancer du cou ?\nComment se manifeste une infection des ganglions ?\nQuels signes d'alerte nécessitent une consultation rapide ?\nLes douleurs au cou sont-elles toujours liées à un cancer ?\nQuels symptômes post-opératoires sont normaux ?",
"url": "https://questionsmedicales.fr/mesh/D037981?mesh_terms=Geographic+Atrophy#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Évidement ganglionnaire cervical",
"description": "Comment prévenir le cancer du cou ?\nLes vaccinations peuvent-elles aider ?\nQuel rôle joue le dépistage précoce ?\nComment réduire le risque d'infections ?\nLes examens réguliers sont-ils importants ?",
"url": "https://questionsmedicales.fr/mesh/D037981?mesh_terms=Geographic+Atrophy#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Évidement ganglionnaire cervical",
"description": "Quel est le but de l'évidement ganglionnaire ?\nQuels types d'évidement existent ?\nQuelles sont les alternatives à l'évidement ?\nComment se déroule l'intervention chirurgicale ?\nQuels soins sont nécessaires après l'évidement ?",
"url": "https://questionsmedicales.fr/mesh/D037981?mesh_terms=Geographic+Atrophy#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Évidement ganglionnaire cervical",
"description": "Quelles sont les complications possibles après l'évidement ?\nComment gérer une infection post-opératoire ?\nQuels signes indiquent une complication grave ?\nLes cicatrices sont-elles inévitables ?\nComment prévenir les complications ?",
"url": "https://questionsmedicales.fr/mesh/D037981?mesh_terms=Geographic+Atrophy#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Évidement ganglionnaire cervical",
"description": "Quels sont les principaux facteurs de risque du cancer du cou ?\nLe sexe influence-t-il le risque de cancer ?\nL'âge joue-t-il un rôle dans le risque ?\nUne mauvaise hygiène buccale est-elle un facteur de risque ?\nLes antécédents familiaux influencent-ils le risque ?",
"url": "https://questionsmedicales.fr/mesh/D037981?mesh_terms=Geographic+Atrophy#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer un cancer nécessitant un évidement ganglionnaire ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un diagnostic est établi par biopsie, imageries (IRM, TDM) et examens cliniques."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour évaluer les ganglions lymphatiques ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les échographies, TDM et IRM sont couramment utilisés pour évaluer les ganglions."
}
},
{
"@type": "Question",
"name": "Quels signes cliniques indiquent un besoin d'évidement ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des ganglions enflés, durs ou douloureux peuvent indiquer un besoin d'évidement."
}
},
{
"@type": "Question",
"name": "Quelle est l'importance de l'examen histologique ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'examen histologique permet de confirmer la présence de cellules cancéreuses dans les ganglions."
}
},
{
"@type": "Question",
"name": "Quand un scanner est-il recommandé ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un scanner est recommandé pour évaluer l'extension du cancer et planifier l'intervention."
}
},
{
"@type": "Question",
"name": "Quels symptômes peuvent indiquer un cancer du cou ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des ganglions enflés, douleur au cou, difficulté à avaler."
}
},
{
"@type": "Question",
"name": "Comment se manifeste une infection des ganglions ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une infection peut provoquer douleur, rougeur, chaleur et gonflement des ganglions."
}
},
{
"@type": "Question",
"name": "Quels signes d'alerte nécessitent une consultation rapide ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des ganglions persistants, une perte de poids inexpliquée ou des sueurs nocturnes sont alarmants."
}
},
{
"@type": "Question",
"name": "Les douleurs au cou sont-elles toujours liées à un cancer ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, les douleurs au cou peuvent être causées par diverses conditions, pas seulement le cancer."
}
},
{
"@type": "Question",
"name": "Quels symptômes post-opératoires sont normaux ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un léger gonflement et des douleurs au site chirurgical sont normaux après l'intervention."
}
},
{
"@type": "Question",
"name": "Comment prévenir le cancer du cou ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éviter le tabac, limiter l'alcool et adopter une alimentation saine peuvent aider."
}
},
{
"@type": "Question",
"name": "Les vaccinations peuvent-elles aider ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la vaccination contre le HPV peut réduire le risque de cancers oropharyngés."
}
},
{
"@type": "Question",
"name": "Quel rôle joue le dépistage précoce ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le dépistage précoce permet de détecter le cancer à un stade plus traitable."
}
},
{
"@type": "Question",
"name": "Comment réduire le risque d'infections ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Maintenir une bonne hygiène buccale et éviter les contacts avec des personnes malades aide."
}
},
{
"@type": "Question",
"name": "Les examens réguliers sont-ils importants ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des examens réguliers permettent de détecter des anomalies précocement."
}
},
{
"@type": "Question",
"name": "Quel est le but de l'évidement ganglionnaire ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'évidement vise à retirer les ganglions lymphatiques affectés pour contrôler le cancer."
}
},
{
"@type": "Question",
"name": "Quels types d'évidement existent ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il existe l'évidement sélectif, radical et modéré, selon l'étendue de la maladie."
}
},
{
"@type": "Question",
"name": "Quelles sont les alternatives à l'évidement ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les alternatives incluent la radiothérapie et la chimiothérapie, selon le cas."
}
},
{
"@type": "Question",
"name": "Comment se déroule l'intervention chirurgicale ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'intervention se fait sous anesthésie générale, avec une incision pour retirer les ganglions."
}
},
{
"@type": "Question",
"name": "Quels soins sont nécessaires après l'évidement ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des soins de plaie, gestion de la douleur et suivi médical sont nécessaires après l'opération."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications possibles après l'évidement ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent infections, saignements, et lésions nerveuses."
}
},
{
"@type": "Question",
"name": "Comment gérer une infection post-opératoire ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une infection peut nécessiter des antibiotiques et un suivi médical régulier."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent une complication grave ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des douleurs intenses, fièvre élevée ou écoulement anormal doivent alerter."
}
},
{
"@type": "Question",
"name": "Les cicatrices sont-elles inévitables ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des cicatrices sont inévitables, mais leur apparence peut s'améliorer avec le temps."
}
},
{
"@type": "Question",
"name": "Comment prévenir les complications ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Suivre les instructions post-opératoires et signaler tout symptôme anormal aide à prévenir."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque du cancer du cou ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les principaux facteurs incluent le tabagisme, l'alcool, et l'exposition au HPV."
}
},
{
"@type": "Question",
"name": "Le sexe influence-t-il le risque de cancer ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains cancers du cou sont plus fréquents chez les hommes que chez les femmes."
}
},
{
"@type": "Question",
"name": "L'âge joue-t-il un rôle dans le risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le risque de cancer du cou augmente avec l'âge, surtout après 50 ans."
}
},
{
"@type": "Question",
"name": "Une mauvaise hygiène buccale est-elle un facteur de risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une mauvaise hygiène buccale peut augmenter le risque de cancers oropharyngés."
}
},
{
"@type": "Question",
"name": "Les antécédents familiaux influencent-ils le risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents familiaux de cancer augmentent le risque de développer un cancer."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 22/03/2025
Contenu vérifié selon les dernières recommandations médicales
2 publications dans cette catégorie
Affiliations :
Department of Otolaryngology, University of Pittsburgh, 203 Lothrop Street, Suite 500, Pittsburgh, PA 15213, USA; Department of Veterans Affairs, Pittsburgh Health System, University Drive C, Pittsburgh, PA 15240, USA. Electronic address: duvvuriu@upmc.edu.
Publications dans "Évidement ganglionnaire cervical" :
2 publications dans cette catégorie
Affiliations :
Clinical Anatomy Research Association in Oral and Maxillofacial Surgery, Fukuoka, Japan.
Department of Oral and Maxillofacial Anatomy, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan.
Department of Neurosurgery, Tulane Center for Clinical Neurosciences, Tulane University School of Medicine, New Orleans, LA, USA.
Department of Neurology, Tulane Center for Clinical Neurosciences, Tulane University School of Medicine, New Orleans, LA, USA.
Department of Structural & Cellular Biology, Tulane University School of Medicine, New Orleans, LA, USA.
Dental and Oral Medical Center, Kurume University School of Medicine, Fukuoka, Japan.
Division of Gross and Clinical Anatomy, Department of Anatomy, Kurume University School of Medicine, Fukuoka, Japan.
Department of Neurosurgery and Ochsner Neuroscience Institute, Ochsner Health System, New Orleans, LA, USA.
Publications dans "Évidement ganglionnaire cervical" :
2 publications dans cette catégorie
Affiliations :
Clinical Anatomy Research Association in Oral and Maxillofacial Surgery, Fukuoka, Japan.
Department of Neurosurgery, Tulane Center for Clinical Neurosciences, Tulane University School of Medicine, New Orleans, LA, USA.
Department of Neurology, Tulane Center for Clinical Neurosciences, Tulane University School of Medicine, New Orleans, LA, USA.
Department of Structural & Cellular Biology, Tulane University School of Medicine, New Orleans, LA, USA.
Department of Neurosurgery and Ochsner Neuroscience Institute, Ochsner Health System, New Orleans, LA, USA.
Department of Anatomical Sciences, St. George's University, St. George's, Grenada.
Department of Surgery, Tulane University School of Medicine, New Orleans, LA, USA.
University of Queensland, Brisbane, Australia.
Publications dans "Évidement ganglionnaire cervical" :
2 publications dans cette catégorie
Affiliations :
Department of Otolaryngology-Head and Neck Surgery, Rutgers New Jersey Medical School, Newark, New Jersey, USA.
Publications dans "Évidement ganglionnaire cervical" :
2 publications dans cette catégorie
Affiliations :
Department of Otolaryngology-Head and Neck Surgery, Rutgers New Jersey Medical School, Newark, New Jersey, USA.
Publications dans "Évidement ganglionnaire cervical" :
2 publications dans cette catégorie
Affiliations :
Department of Otolaryngology-Head and Neck Surgery, Rutgers New Jersey Medical School, Newark, New Jersey, USA.
Publications dans "Évidement ganglionnaire cervical" :
2 publications dans cette catégorie
Affiliations :
Department of Otolaryngology-Head and Neck, Maxillofacial Surgery, Israel.
Publications dans "Évidement ganglionnaire cervical" :
2 publications dans cette catégorie
Affiliations :
Department of Otolaryngology-Head and Neck, Maxillofacial Surgery, Israel.
Publications dans "Évidement ganglionnaire cervical" :
2 publications dans cette catégorie
Affiliations :
Department of Otolaryngology-Head and Neck, Maxillofacial Surgery, Israel.
Publications dans "Évidement ganglionnaire cervical" :
2 publications dans cette catégorie
Affiliations :
Department of Otolaryngology-Head and Neck, Maxillofacial Surgery, Israel.
Publications dans "Évidement ganglionnaire cervical" :
2 publications dans cette catégorie
Affiliations :
Department of Head and Neck Surgery & Communication Sciences, Duke University School of Medicine, Durham, NC, USA.
Publications dans "Évidement ganglionnaire cervical" :
2 publications dans cette catégorie
Affiliations :
Department of Head and Neck Surgery & Communication Sciences, Duke University School of Medicine, Durham, NC, USA.
Publications dans "Évidement ganglionnaire cervical" :
2 publications dans cette catégorie
Affiliations :
Department of Head and Neck Surgery & Communication Sciences, Duke University School of Medicine, Durham, NC, USA.
Publications dans "Évidement ganglionnaire cervical" :
2 publications dans cette catégorie
Affiliations :
Centre des Hautes Energies, Department of Radiotherapy, 06000 Nice, France.
Publications dans "Évidement ganglionnaire cervical" :
2 publications dans cette catégorie
Affiliations :
Department of General Surgery, Division of Endocrine Surgery, University of Health Sciences Turkey, Sisli Hamidiye Etfal Training and Research Hospital, Istanbul, Turkey.
Publications dans "Évidement ganglionnaire cervical" :
2 publications dans cette catégorie
Affiliations :
Department of General Surgery, Sisli Memorial Hospital, Istanbul, Turkey.
Publications dans "Évidement ganglionnaire cervical" :
2 publications dans cette catégorie
Affiliations :
Department of General Surgery, Division of Endocrine Surgery, University of Health Sciences Turkey, Sisli Hamidiye Etfal Training and Research Hospital, Istanbul, Turkey.
Publications dans "Évidement ganglionnaire cervical" :
2 publications dans cette catégorie
Affiliations :
National Cancer Center Hospital, Tokyo, Japan.
Publications dans "Évidement ganglionnaire cervical" :
2 publications dans cette catégorie
Affiliations :
Department of Surgery, Mayo Clinic, Rochester, Minnesota. Electronic address: strajina.veljko@mayo.edu.
Publications dans "Évidement ganglionnaire cervical" :
2 publications dans cette catégorie
Affiliations :
Department of Surgery, Mayo Clinic, Rochester, Minnesota.
Publications dans "Évidement ganglionnaire cervical" :
Age-related macular degeneration (AMD) is one of the leading causes of blindness and can progress to geographic atrophy (GA) in late stages of disease. This review article highlights recent literature...
Technology for diagnosing and monitoring GA has made significant advances in recent years, particularly regarding the use of optical coherence tomography (OCT). Identification of imaging features whic...
Identification of GA and of risk factors for GA development or progression is essential when counseling AMD patients and discussing prognosis. With new therapies on the horizon for the treatment of GA...
Geographic atrophy (GA) is a late-stage form of age-related macular degeneration (AMD) characterized by the expansion of atrophic lesions in the outer retina. There are currently no approved pharmacol...
A literature search on GA was conducted....
Expansion of atrophic lesions in patients with GA is associated with a decline in several measures of visual function. GA lesion size has been moderately associated with measures obtained through micr...
GA is a progressive disease associated with irreversible vision loss. Therefore, the lack of treatment options presents a significant unmet need. OCT and drugs under investigation for GA are promising...
With the prospect of available therapy for geographic atrophy in the near future and consequently increasing patient numbers, appropriate management strategies for the clinical practice are needed. Op...
To elucidate the clinical characteristics and progression rate of geographic atrophy (GA) associated with age-related macular degeneration (AMD) in a Japanese population....
Retrospective, multicenter, observational study....
A total of 173 eyes from 173 patients from 6 university hospitals in Japan were included. Of 173 study eyes, 101 eyes from 101 patients were included in the follow-up group. All patients were Japanese...
The GA area was measured semiautomatically using fundus autofluorescence (FAF) images. In the follow-up group followed for > 6 months with FAF images, the GA progression rate was calculated by 2 metho...
Clinical characteristics of GA and the GA progression rate....
The mean age was 76.8 ± 8.8 years, and 109 (63.0%) were males. Sixty-two (35.8%) patients had bilateral GA. The mean GA area was 3.06 ± 4.00 mm...
Certain clinical characteristics of GA in Asian populations may differ from those in White populations. Asian patients with GA showed male dominance and relatively thicker choroid than White patients....
Proprietary or commercial disclosure may be found in the Footnotes and Disclosures at the end of this article....
To compare clinical and imaging characteristics of extensive macular atrophy with pseudodrusen-like appearance (EMAP) versus diffuse-trickling geographic atrophy (DTGA) and non-diffuse-trickling geogr...
Geographic atrophy (GA) is currently an untreatable condition. Emerging evidence from recent clinical trials show that anti-complement therapy may be a successful treatment option. However, several tr...
To describe the occurrence, rate of geographic atrophy (GA) expansion, and changes in visual acuity (VA) after reabsorption of subfoveal pigment epithelial detachments (PED)....
Included patients had reabsorption of a PED followed by GA. Patients underwent clinical examination with SD-OCT. Images were classified by size with grading occurring post reabsorption. VA was recorde...
The average age of the cohort, consisting of 22 eyes from 19 participants, was 86.9 years at reabsorption. Prior to reabsorption, the VA was 20/80 and then declined to 20/200 (p = 0.001) with an avera...
This study longitudinally examined GA growth rate in patients with reabsorbed PEDs. These patients started with a drusenoid or serous PED, had a dramatic reduction in vision and GA that occurred in pl...
To investigate the association of nascent geographic atrophy (GA) preceding the development of exudative type 3 macular neovascularization (MNV) in patients with age-related macular degeneration (AMD)...
Retrospective longitudinal study....
Patients with AMD diagnosed with treatment-naive exudative type 3 MNV in 1 or both eyes were evaluated. Inclusion criteria included serial tracked structural OCT examinations for ≥ 2 years before the ...
Clinical characteristics and retinal imaging, including structural OCT at baseline and at each follow-up examination, were analyzed. Eyes showing the presence of nascent GA during the follow-up were s...
Description of the prevalence and clinical characteristics of nascent GA at the site of subsequent type 3 MNV development....
Overall, 97 eyes affected by type 3 MNV meeting inclusion criteria were analyzed. Of 97 eyes (71 patients), 22 eyes of 21 patients (mean age 82 ± 9 years) showed nascent GA preceding exudative type 3 ...
As nascent GA may precede the development of exudative type 3 MNV, the detection of nascent GA in eyes with AMD may warrant closer surveillance to identify early exudative type 3 MNV warranting treatm...
Proprietary or commercial disclosure may be found after the references....
Geographic Atrophy (GA) is the advanced form of the non-neovascular ('dry') type of age-related macular degeneration (AMD) and responsible for one-quarter of legal blindness in the UK. New therapies d...
Twenty-eight participants took part in this exercise. The exercise demonstrated that participants were generally, although not unanimously, in favour of less frequent treatment for GA that was slightl...
The atrophic late stage of age-related macular degeneration (AMD) is termed geographic atrophy (GA), and affects visual acuity (VA) as well as quality of life (QoL). Previous studies have found that b...
This was prospective clinical study of 51 patients with GA in one or both eyes, of these 45 patients had bilateral GA. Patients were consecutively included between April 2021 and February 2022. All pa...
We found an overall low score in each VFQ-39 subscale scores reflected by GA. Lesion size and VA were both significantly associated with all VFQ-39 subscale scores except for "general health." VA show...
Both atrophic lesion size and visual acuity affects QoL in Danish patients with GA, who reports an overall poor QoL. CVD seems to have a negative effect on disease, as well as in VFQ-39 in several sub...